National Quality Assessment Evaluating Spironolactone Use During Hospitalization for Acute Myocardial Infarction (AMI) in China: China Patient-centered Evaluation Assessment of Cardiac Events (PEACE)-Retrospective AMI Study, 2001, 2006, and 2011

BACKGROUND: Spironolactone, the only aldosterone antagonist available in China, improves outcomes in acute myocardial infarction (AMI) among patients with systolic dysfunction and either diabetes or heart failure (HF). However, national practice patterns in the use of spironolactone in China are unk...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:J Am Heart Assoc
Κύριοι συγγραφείς: Guan, Wenchi, Murugiah, Karthik, Downing, Nicholas, Li, Jing, Wang, Qing, Ross, Joseph S, Desai, Nihar R, Masoudi, Frederick A, Spertus, John A, Li, Xi, Krumholz, Harlan M, Jiang, Lixin
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: John Wiley & Sons, Ltd 2015
Θέματα:
Original Research
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4599529/
https://ncbi.nlm.nih.gov/pubmed/26071031
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.114.001718
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια